Mitybos pažanga - Company finances
|
EUR
|
2023
From: 2023-05-17
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 31,375 | 232,837 | 238,465 |
| Profit before tax | 8,363 | 117,950 | 101,627 |
| Net profit | 8,363 | 112,052 | 95,174 |
| Equity | 8,364 | 98,916 | 128,561 |
| Liabilities | 0 | 2,866 | 17,371 |
| Non-current assets | 0 | 0 | 1,929 |
| Current assets | 8,364 | 101,782 | 144,003 |
| Total assets | 8,364 | 101,782 | 145,932 |
|
Taxes paid
|
|||
| STI taxes | 27 | 4 | 5,903 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +642.1% | +2.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 100.0% | 110.1% | 65.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | 113.3% | 74.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 26.7% | 48.1% | 39.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 26.7% | 50.7% | 42.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.0 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Mitybos pažanga - Social security debts
The company had no debts to Sodra
Mitybos pažanga - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-09-14 | 2026-09-14 | 0.0 |
| 2026-09-02 | 2026-09-13 | 601.94 |
| 2026-08-31 | 2026-09-01 | 601.94 |
| 2026-08-30 | 2026-08-30 | 601.94 |
| 2026-08-28 | 2026-08-29 | 601.94 |
| 2026-08-26 | 2026-08-27 | 0.64 |
| 2026-08-25 | 2026-08-25 | 0.64 |
| 2026-08-23 | 2026-08-24 | 0.64 |
| 2026-08-20 | 2026-08-22 | 0.64 |
| 2026-08-19 | 2026-08-19 | 0.64 |
| 2026-08-18 | 2026-08-18 | 0.64 |
| 2026-08-17 | 2026-08-17 | 0.64 |
| 2026-08-13 | 2026-08-16 | 0.64 |
| 2026-08-12 | 2026-08-12 | 0.64 |
| 2026-08-10 | 2026-08-11 | 0.64 |
| 2026-08-09 | 2026-08-09 | 0.64 |
| 2026-08-07 | 2026-08-08 | 0.64 |
| 2026-08-06 | 2026-08-06 | 0.64 |
| 2026-08-05 | 2026-08-05 | 602.87 |
| 2026-08-03 | 2026-08-04 | 602.87 |
| 2026-07-26 | 2026-08-02 | 0.0 |
| 2026-07-07 | 2026-07-25 | 0.0 |
| 2026-07-06 | 2026-07-06 | 0.0 |
| 2026-06-29 | 2026-07-05 | 5.2 |
| 2025-07-21 | 2025-07-29 | 46.11 |
| 2025-06-19 | 2025-07-20 | 5898.0 |
| 2025-02-20 | 2025-02-27 | 5.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Mitybos pažanga, MB (code 306320070) is a small partnership engaged in medical specialists activities. In 2025, revenue reached €238.5K, up 2.4% year on year from €232.8K in 2024 and well above €31.4K in 2023, showing a strong expansion in scale over two years. Net profit was €95.2K in 2025, down from €112.1K in 2024 but still significantly higher than €8.4K in 2023. Profitability remained strong, with a 39.9% net margin in 2025 after 48.1% in 2024 and 26.7% in 2023. The balance sheet strengthened further in 2025: total assets increased to €145.9K from €101.8K a year earlier, equity rose to €128.6K, and liabilities were €17.4K. The equity ratio stood at 88.1%, debt-to-equity at 0.14, asset turnover at 1.63x, ROE at 74.0% and ROA at 65.2%. Overall, the company shows a profitable and lightly leveraged profile with strong asset efficiency and continued capital growth in 2025.